NCCN Guidelines Insights: Cervical Cancer, Version 1.2020.

Published

Journal Article

The NCCN Guidelines for Cervical Cancer provide recommendations for diagnostic workup, staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to first- and second-line systemic therapy recommendations for patients with recurrent or metastatic disease, and emerging evidence on a new histopathologic classification system for HPV-related endocervical adenocarcinoma.

Full Text

Duke Authors

Cited Authors

  • Abu-Rustum, NR; Yashar, CM; Bean, S; Bradley, K; Campos, SM; Chon, HS; Chu, C; Cohn, D; Crispens, MA; Damast, S; Fisher, CM; Frederick, P; Gaffney, DK; Giuntoli, R; Han, E; Huh, WK; Lurain Iii, JR; Mariani, A; Mutch, D; Nagel, C; Nekhlyudov, L; Fader, AN; Remmenga, SW; Reynolds, RK; Sisodia, R; Tillmanns, T; Ueda, S; Urban, R; Wyse, E; McMillian, NR; Motter, AD

Published Date

  • June 2020

Published In

Volume / Issue

  • 18 / 6

Start / End Page

  • 660 - 666

PubMed ID

  • 32502976

Pubmed Central ID

  • 32502976

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2020.0027

Language

  • eng

Conference Location

  • United States